Bank of Montreal’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8K | Hold |
730
| – | – | ﹤0.01% | 2848 |
|
|
2025
Q1 | $46.3K | Hold |
730
| – | – | ﹤0.01% | 2804 |
|
|
2024
Q4 | $48.6K | Sell |
730
-2,735
| -79% | -$182K | ﹤0.01% | 2802 |
|
|
2024
Q3 | $242K | Hold |
3,465
| – | – | ﹤0.01% | 2609 |
|
|
2024
Q2 | $230K | Hold |
3,465
| – | – | ﹤0.01% | 2640 |
|
|
2024
Q1 | $227K | Hold |
3,465
| – | – | ﹤0.01% | 2669 |
|
|
2023
Q4 | $231K | Hold |
3,465
| – | – | ﹤0.01% | 2627 |
|
|
2023
Q3 | $213K | Hold |
3,465
| – | – | ﹤0.01% | 2628 |
|
|
2023
Q2 | $220K | Buy |
3,465
+2,735
| +375% | +$174K | ﹤0.01% | 2783 |
|
|
2023
Q1 | $47.7K | Hold |
730
| – | – | ﹤0.01% | 3092 |
|
|
2022
Q4 | $48.6K | Sell |
730
-95
| -12% | -$6.33K | ﹤0.01% | 3108 |
|
|
2022
Q3 | $54 | Hold |
825
| – | – | ﹤0.01% | 3138 |
|
|
2022
Q2 | $49 | Sell |
825
-57
| -6% | -$3 | ﹤0.01% | 3178 |
|
|
2022
Q1 | $55K | Hold |
882
| – | – | ﹤0.01% | 3266 |
|
|
2021
Q4 | $64K | Buy |
882
+465
| +112% | +$33.7K | ﹤0.01% | 3125 |
|
|
2021
Q3 | $32K | Hold |
417
| – | – | ﹤0.01% | 3385 |
|
|
2021
Q2 | $33K | Buy |
+417
| New | +$33K | ﹤0.01% | 3332 |
|
|
2016
Q4 | – | Sell |
-200
| Closed | -$8K | – | 3784 |
|
|
2016
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 3345 |
|
|
2016
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 3382 |
|
|
2016
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 3414 |
|
|
2015
Q4 | $10K | Buy |
+200
| New | +$10K | ﹤0.01% | 3386 |
|
|
2014
Q3 | – | Sell |
-1,000
| Closed | -$44K | – | 3793 |
|
|
2014
Q2 | $44K | Hold |
1,000
| – | – | ﹤0.01% | 2847 |
|
|
2014
Q1 | $42K | Hold |
1,000
| – | – | ﹤0.01% | 2691 |
|
|
2013
Q4 | $37K | Hold |
1,000
| – | – | ﹤0.01% | 2655 |
|
|
2013
Q3 | $35K | Buy |
+1,000
| New | +$35K | ﹤0.01% | 2588 |
|